Author:
Sukmawaty Muli,Sartini ,Permana Andi Dian,Mudjahid Mukarram,Roska Tri Puspita,Rahman Latifah
Funder
Kementerian Riset Teknologi Dan Pendidikan Tinggi Republik Indonesia
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science
Reference49 articles.
1. Akhtar S, Masood S, Tabassum S, Rizvi DA. Efficacy of itraconazole versus fluconazole in vaginal candidiasis. J Pakistan Med Assoc. 2012;62.
2. Botros SR, Hussein AK, Mansour HF. A novel nanoemulsion intermediate gel as a promising approach for delivery of itraconazole: design, in vitro and ex vivo appraisal. AAPS PharmSciTech. 2020;21:12–4. https://doi.org/10.1208/s12249-020-01830-w.
3. Bagavatula H, Lankalapalli S, Tenneti VVK, Beeraka NMR, Bulusu BT. Comparative studies on solubility and dissolution enhancement of different itraconazole salts and their complexes. Adv Pharmacol Pharm. 2014;2:85–95. https://doi.org/10.13189/app.2014.020601.
4. Kalia K, Poddar M. Solid dispersions: an approach towards enhancing dissolution rate. Int J Pharm Pharm Sci. 2011;3(9–19).
5. Permana AD, Utomo E, Pratama MR, Amir MuhN, Anjani QK, Mardikasari SA, et al. Bioadhesive-thermosensitive in situ vaginal gel of the gel flake-solid dispersion of itraconazole for enhanced antifungal activity in the treatment of vaginal candidiasis. ACS Appl Mater Interfaces. 2021. https://doi.org/10.1021/acsami.1c03422.